TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Revenue

TScan Therapeutics had revenue of $982.00K in the quarter ending March 31, 2026, a decrease of -54.77%. This brings the company's revenue in the last twelve months to $9.14M, up 106.65% year-over-year. In the year 2025, TScan Therapeutics had annual revenue of $10.33M with 266.65% growth.

• Revenue (ttm): $9.14M
• Revenue Growth: +106.65%
• P/S Ratio: 6.58
• Revenue / Employee: $64,338
• Employees: 142
• Market Cap: 60.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.33M	7.51M	266.65%
Dec 31, 2024	2.82M	-18.23M	-86.62%
Dec 31, 2023	21.05M	7.51M	55.52%
Dec 31, 2022	13.54M	3.39M	33.47%
Dec 31, 2021	10.14M	9.06M	834.65%
Dec 31, 2020	1.09M	-	-
Dec 31, 2019	-	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error